03 October 2012

South Africa’s Aspen to create 44 new jobs in Ireland

03 October 2012 - Minister for Jobs, Enterprise and Innovation, Richard Bruton TD, today announced that Aspen, one of the leading generic pharmaceutical companies in the world, is to create 44 new high quality jobs. The company first established an operation in Ireland in 2010 which has now become Aspen’s European Marketing and Supply Chain Headquarters; in addition the company is now establishing a global regulatory, pharmacovigilance, quality assurance and supply projects centre of excellence in Citywest. The announcement is supported by the Irish Government through IDA Ireland. 

In addition to being one of the largest generic global pharmaceutical companies Aspen is also the largest producer of anti-retroviral (HIV) drugs in South Africa. The new jobs will bring Aspen’s total workforce in Ireland to 58. 

Making the announcement, Minister for Jobs, Enterprise and Innovation, Richard Bruton TD said: “Pharmaceuticals is a major sector of strength for Ireland, with nine out of the top ten global companies located here. However a key part of the Government’s plan for jobs and growth is targeting the areas of growth within what is a changing sector – in particular, generics. Today’s announcement that Aspen, one of the world’s leading generic pharmaecutical companies is expanding its operations here is very welcome news. I am determined to ensure that we build on this to target further generics investments to create the jobs and growth we need”. 

Welcoming the announcement, Stephen Saad, group Chief Executive of Aspen said, ‘I am delighted to see the continued growth of Aspen here in Ireland. Ireland provides for us a workforce with the specialised skills we require and a strong regulatory and business environment. I would like to thank the Irish Government and IDA Ireland for their support and look forward to the future development of Aspen in Ireland.’ 

Commenting on the announcement, Barry O’Leary, CEO of IDA Ireland said, ‘Aspen’s decision to locate this operation here adds to Ireland’s cluster of life science companies and will add to our reputation as a leading centre for this sector. A key member of this cluster in Ireland is GlaxoSmithKline which owns a 20% share of Aspen. Ireland offers South Africa’s largest pharmaceutical company a strategic location from which to support its ongoing expansion and grow its sales across Europe. I wish Aspen every success with this expansion and look forward to continue to work closely with the company as it further embeds its operations here.’ 

Source: IDA Ireland